Following acquisition, Tracer Drone accelerates fleet expansion and operational readiness, with services spanning pilot certification preparation to turnkey Drone as First Responder systems. HOBOKEN, N.J.
Rocket One Inc. (RKTO) shows a pre-commercial immunology profile in which operating losses of $1.6M to $4.1M per quarter and operating cash burn of roughly $2M to $3M per quarter have persisted with only $35 of revenue reported in 2026Q3.
Price trend, volume and key moving averages
Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 13, 2026 | -$0.11+28.6% vs -$0.15 | $35+0.0% vs $35 |
Q3 2026 Aug 14, 2026 | -$0.19-33.4% vs -$0.14 | — vs — |
Q2 2026 May 15, 2026 | -$0.17-23.4% vs -$0.14 | — vs — |
Q2 2026 Mar 27, 2026 | -$0.16-55.2% vs -$0.10 | — vs — |
Following acquisition, Tracer Drone accelerates fleet expansion and operational readiness, with services spanning pilot certification preparation to turnkey Drone as First Responder systems. HOBOKEN, N.J.
Positive interim findings drive early trial conclusion; Hoth prepares to seek FDA alignment on a potential pivotal study for cancer treatment–related skin toxicity HOBOKEN, N.J., Nov. 3, 2026 /PRNewswire/ -- Rocket One Inc. (Nasdaq: RKTO) ("Rocket One" or the "Company") today announced that its biotechnology subsidiary, Hoth Therapeutics, has decided to end its Phase 2a clinical trial of HT-001 early following strong interim efficacy results.
Benchmark RKTO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Rocket One Inc. (RKTO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.32 | $7.83M | -0.66 | — | -33984280% | -183.44% | — | |
| $4.73 | $2.45B | 212.11 | 40.34% | 0.45% | 3.52% | — | |
| $1.62 | $712.96K | -0.10 | -100% | — | — | — | |
| $2.45 | $42.35M | -5.35 | — | -458.48% | — | — | |
| $0.59 | $7.6M | -1.48 | 11.8% | -12.72% | -110.3% | — | |
| $13.88 | $90.43M | -4.95 | -10.02% | -6.33% | -32.09% | — |
Rocket One Inc. (RKTO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Rocket One Inc. (RKTO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Sep 25, 2026·SEC
Sep 22, 2026·SEC
Aug 11, 2026·SEC
Get notified when RKTO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Rocket One Inc. (RKTO) stock FAQ — growth, dividends, profitability & financials explained
Rocket One Inc. (RKTO) reported $0.0M in revenue over the trailing twelve months.
No. Rocket One Inc. (RKTO) reported a net loss of $11.9M over the trailing twelve months.
Rocket One Inc. (RKTO) had a return on equity (ROE) of -183.4% over the trailing twelve months. A negative ROE means the company lost money over the period.
Rocket One Inc. (RKTO) had negative free cash flow of $11.0M over the trailing twelve months.